Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Other Working Capital Changes (2021 - 2026)

Biomea Fusion (BMEA) posted Other Working Capital Changes of -$350000.0 for Q1 2026, down 24.11% sequentially from -$282000.0 in Q4 2025, and up 58.53% YoY from -$220777.3 in Q1 2025.

Biomea Fusion (BMEA) Other Working Capital Changes (2021 - 2026) Analysis & Trends

Biomea Fusion has reported Other Working Capital Changes for 6 years, with the latest figure at -$350000.0 in Q1 2026.

  • Quarterly Other Working Capital Changes rose 58.53% year-over-year to -$350000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 million (up 40.82% YoY) and the FY2025 annual result came in at -$2.2 million, down 45.04% from the prior year.
  • Other Working Capital Changes eased to -$350000.0 in Q1 2026 per BMEA's latest filing, from -$282000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $4.4 million in Q4 2024 and troughed at -$5.6 million in Q3 2025.
  • A 5-year average of -$106588.2 and a median of $25000.0 in 2022 frame the typical range for Other Working Capital Changes.
  • The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes tumbled 343.06% in 2023, then jumped 186.78% in 2024.
  • Over 5 years, Other Working Capital Changes stood at -$146000.0 in 2022, then tumbled by 179.45% to -$408000.0 in 2023, then slumped by 94.85% to -$795000.0 in 2024, then soared by 64.53% to -$282000.0 in 2025, then retreated by 24.11% to -$350000.0 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$350000.0, -$282000.0, and -$177000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Biomea Fusion 97.69 Mn 97.69 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -362,000.00
Jun 30, 2026 -362,000.00
Jun 30, 2026 -362,000.00
Mar 31, 2026 -350,000.00
Mar 31, 2026 -350,000.00
Mar 31, 2026 -350,000.00
Dec 31, 2025 -282,000.00
Dec 31, 2025 -282,000.00
Dec 31, 2025 -282,000.00
Sep 30, 2025 -177,000.00
Sep 30, 2025 -177,000.00
Sep 30, 2025 -177,000.00
Jun 30, 2025 -874,000.00
Jun 30, 2025 -874,000.00
Jun 30, 2025 -874,000.00
Mar 31, 2025 -844,000.00
Mar 31, 2025 -844,000.00
Mar 31, 2025 -844,000.00
Dec 31, 2024 -795,000.00
Dec 31, 2024 -795,000.00